Skip to content

The longitudinal invsetigation of osteoarthritis and cardiovascular health status

The longitudinal invsetigation of osteoarthritis and cardiovascular health status

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071492
Enrollment
Unknown
Registered
2023-05-16
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease, osteoarthritis

Interventions

Exposed/non-exposed:No intervention

Sponsors

Luohe Central Hospital, Luohe Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Middle-aged and elderly people (35-75) living in Luohe and surrounding areas; 2. Have a clear history of cardiovascular disease (coronary heart disease or stroke) or risk factors for cardiovascular disease (smoking, diabetes, hypertension, or hyperlipidemia); 3. Willing to receive an ultrasonic scan of the heart and carotid arteries, as well as X-ray and ultrasound imaging of the shoulder joint, knee joint, and hip joint to complete the assessment of cardiovascular disease and osteoarthritis; 4. willing and able to participate in a follow-up of at least 5 years.

Exclusion criteria

Exclusion criteria: 1. Patients in the acute phase of acute myocardial infarction, cardiogenic shock, end-stage heart failure, or those whose hemodynamics were unstable due to other causes; 2. Patients with a confirmed diagnosis of malignant tumors, severe trauma, burns, car accidents, or other life-threatening conditions that significantly impacted life expectancy; 3. patients with severe psychological abnormalities, consciousness disorders, cognitive dysfunction, or those who were unable to cooperate with questionnaire surveys.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events, which encompassed all-cause mortality/cardiovascular disease mortality, non-fatal myocardial infarction, and stroke.;

Secondary

MeasureTime frame
assessment of cardiovascular disease risk factors, evaluation of cardiac and vascular structure and function, overall cardiovascular disease risk assessment, readmissions, percutaneous coronary intervention, and coronary artery bypass grafting.;

Countries

China

Contacts

Public ContactDongliang Liu, Haoran Wang

Luohe Central Hospital, Luohe Medical College

washingtonhr@163.com+86 395 333 0559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 14, 2026